drugset / Trial / NCT04440982

Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

NCT04440982 ↗

RandomizedParallel-groupSingle-blindOther

Summary

This is a prospective, multi-center, randomized, clinical trial evaluating patients undergoing breast conserving surgery using the LUM Imaging System.

Timeline

Start
2020-09-01
Primary completion
2023-11-30
Completion
2024-02-29

Outcome

Outcome not reported

Stopped: “Required resources unavailable.”

Drugs

EvaluationDrugModalityDoseRoute
Subject PEGULICIANINE ACETATE Diagnostic / imaging agent 1 mg/kg —

Indications